Companion Diagnostics Market Industry Analysis By Life Technologies Tm, Sysmex Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Hologic, Inc & Others

Press Release

Global companion diagnostics market is growing at a healthy CAGR of 22.50% during the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. The growth in the market is attributed to the rising of chronic diseases, growing demand for personalized medicine and growing adoption of companion diagnostics.

This companion diagnostics report acts as an excellent market report because it is produced with the several decisive factors. These consist of primary research, benchmarking studies, secondary research, company profiles, competitive intelligence & reporting, syndicated research, data collection, data processing and analysis, survey design, and survey programming. The report also endows with evaluations based on the market type, organization size, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. The companion diagnostics report considers new product development from beginning to launch by performing detailed market study.

Get Sample Copy Of This Report @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-companion-diagnostics-market

Some of the major players operating in global companion diagnostics market are F. Hoffmann-La Roche Ltd., Qiagen, Abbott, Almac Group, Agilent Technologies, Inc., Clinical Lab Products, Myriad Genetics, Inc., Leica Biosystems Nussloch GmbH, Resonance Health, ARUP Laboratories, Life Technologies Tm, Sysmex Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Hologic, Inc., Abnova Corporation, bioMérieux SA, Siemens Healthcare Private Limited  among others.

Key Developments in the Market:

  • In May 2019, QIAGEN received approval on Piqray and fulvestrant combination, which helped to diagnose cancer in the patient. After this approval, Lab corp collaborated with QIAGEN, and broadened QIAGEN market share.
  • In June 2019, Agilent Technologies Inc. received the allowance of FDA on PD-L1 IHC 22C3 pharmDx. This allowance will aid to HNSCC patients for therapy with KEYTRUDA. This approval will expand its use and connect to more patients which will increase company’s revenue.

Competitive Analysis:

Global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of companion diagnostics market for global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography

Get Full Table Of content @   https://www.databridgemarketresearch.com/toc/?dbmr=global-companion-diagnostics-market

Market Drivers

  • Increasing number of genetic testing is enhancing the market growth
  • Improvements in regulatory guidelines drive the market growth
  • Growing need for targeted therapies is flourishing the market growth
  • Rising cancer incidence worldwide acts as a catalyst for the market growth

Market Restraints

  • Increase in cost related to technological advancement is hampering the market growth
  • Reimbursement issues among many countries is restraining the market

Segmentation: Global Companion Diagnostics Market

By Product and Services

  • Assay Kits
  • Reagents
  • Software & Services

By Technology

  • Polymerase Chain Reaction
  • Molecular Diagnostics
  • FISH
  • CISH
  • Immunohistochemistry
  • In-situ Hybridization
  • Real-time PCR
  • Gene Sequencing
  • Next-Generation Sequencing

By Application

  • Colorectal Cancer
  • Breast Cancer
  • Lung Cancer
  • Melanoma
  • Urology
  • Gastric Cancer

By Indication

  • Oncology
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Gastric Cancer
    •  Melanoma
  • Neurology
  • Infectious Diseases

By End Users

  • Pharmaceutical
  • Biopharmaceutical Companies
  • Reference Laboratories
  • Distribution Channel

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Speak to Analyst and Get Free Customized Information about Report @  https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-companion-diagnostics-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

 

Related posts